176 related articles for article (PubMed ID: 1397099)
1. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.
Keski-Oja J; Lohi J; Tuuttila A; Tryggvason K; Vartio T
Exp Cell Res; 1992 Oct; 202(2):471-6. PubMed ID: 1397099
[TBL] [Abstract][Full Text] [Related]
2. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
Lohi J; Harvima I; Keski-Oja J
J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
[TBL] [Abstract][Full Text] [Related]
3. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
4. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
[TBL] [Abstract][Full Text] [Related]
5. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
Xia T; Akers K; Eisen AZ; Seltzer JL
Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
[TBL] [Abstract][Full Text] [Related]
7. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
8. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
Meade-Tollin LC; Way D; Witte MH
Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
[TBL] [Abstract][Full Text] [Related]
9. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
10. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.
Verheijen JH; Nieuwenbroek NM; Beekman B; Hanemaaijer R; Verspaget HW; Ronday HK; Bakker AH
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):603-9. PubMed ID: 9169591
[TBL] [Abstract][Full Text] [Related]
11. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
12. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain.
Rosenberg GA; Dencoff JE; McGuire PG; Liotta LA; Stetler-Stevenson WG
Lab Invest; 1994 Sep; 71(3):417-22. PubMed ID: 7933992
[TBL] [Abstract][Full Text] [Related]
13. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
14. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
15. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
[TBL] [Abstract][Full Text] [Related]
16. Serine protease and metallo protease cascade systems involved in pericellular proteolysis.
Quigley JP; Berkenpas MB; Aimes RT; Chen JM
Cell Differ Dev; 1990 Dec; 32(3):263-75. PubMed ID: 1965954
[TBL] [Abstract][Full Text] [Related]
17. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation.
Koolwijk P; Miltenburg AM; van Erck MG; Oudshoorn M; Niedbala MJ; Breedveld FC; van Hinsbergh VW
J Rheumatol; 1995 Mar; 22(3):385-93. PubMed ID: 7783051
[TBL] [Abstract][Full Text] [Related]
18. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing.
Wysocki AB; Kusakabe AO; Chang S; Tuan TL
Wound Repair Regen; 1999; 7(3):154-65. PubMed ID: 10417751
[TBL] [Abstract][Full Text] [Related]
19. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
Ossowski L
Cancer Res; 1992 Dec; 52(24):6754-60. PubMed ID: 1333882
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]